162 related articles for article (PubMed ID: 28431612)
21. Cerebellar ataxia with oculomotor apraxia type 1: clinical and genetic studies.
Le Ber I; Moreira MC; Rivaud-Péchoux S; Chamayou C; Ochsner F; Kuntzer T; Tardieu M; Saïd G; Habert MO; Demarquay G; Tannier C; Beis JM; Brice A; Koenig M; Dürr A
Brain; 2003 Dec; 126(Pt 12):2761-72. PubMed ID: 14506070
[TBL] [Abstract][Full Text] [Related]
22. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.
Slor H; Batko S; Khan SG; Sobe T; Emmert S; Khadavi A; Frumkin A; Busch DB; Albert RB; Kraemer KH
J Invest Dermatol; 2000 Dec; 115(6):974-80. PubMed ID: 11121128
[TBL] [Abstract][Full Text] [Related]
23. Xeroderma pigmentosum complementation group F: Report of a case and review of Japanese patients.
Tofuku Y; Nobeyama Y; Kamide R; Moriwaki S; Nakagawa H
J Dermatol; 2015 Sep; 42(9):897-9. PubMed ID: 26010807
[TBL] [Abstract][Full Text] [Related]
24. Characterization of molecular defects in xeroderma pigmentosum group F in relation to its clinically mild symptoms.
Matsumura Y; Nishigori C; Yagi T; Imamura S; Takebe H
Hum Mol Genet; 1998 Jun; 7(6):969-74. PubMed ID: 9580660
[TBL] [Abstract][Full Text] [Related]
25. [Siblings with xeroderma pigmentosum group A showing mild cutaneous and various neurological manifestations].
Kuru S; Yasuma M; Sakai M; Konagaya M; Moriwaki S
Rinsho Shinkeigaku; 2006 Feb; 46(2):134-9. PubMed ID: 16619838
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic heterogeneity in the XPB DNA helicase gene (ERCC3): xeroderma pigmentosum without and with Cockayne syndrome.
Oh KS; Khan SG; Jaspers NG; Raams A; Ueda T; Lehmann A; Friedmann PS; Emmert S; Gratchev A; Lachlan K; Lucassan A; Baker CC; Kraemer KH
Hum Mutat; 2006 Nov; 27(11):1092-103. PubMed ID: 16947863
[TBL] [Abstract][Full Text] [Related]
27. A 10-year follow-up of a child with mild case of xeroderma pigmentosum complementation group D diagnosed by whole-genome sequencing.
Ono R; Masaki T; Mayca Pozo F; Nakazawa Y; Swagemakers SM; Nakano E; Sakai W; Takeuchi S; Kanda F; Ogi T; van der Spek PJ; Sugasawa K; Nishigori C
Photodermatol Photoimmunol Photomed; 2016 Jul; 32(4):174-80. PubMed ID: 26993158
[TBL] [Abstract][Full Text] [Related]
28. Gene alterations and clinical characteristics of xeroderma pigmentosum group A patients in Japan.
Nishigori C; Moriwaki S; Takebe H; Tanaka T; Imamura S
Arch Dermatol; 1994 Feb; 130(2):191-7. PubMed ID: 7905727
[TBL] [Abstract][Full Text] [Related]
29. Identification of a novel protein truncating mutation p.Asp98* in XPC associated with xeroderma pigmentosum in a consanguineous Pakistani family.
Ali MZ; Blatterer J; Khan MA; Schaflinger E; Petek E; Ahmad S; Khan E; Windpassinger C
Mol Genet Genomic Med; 2020 Feb; 8(2):e1060. PubMed ID: 31923348
[TBL] [Abstract][Full Text] [Related]
30. Clinical Reasoning: A 60-Year-Old Man With Ataxia, Chorea, and Mild Cognitive Impairment.
Sugiyama A; Nishigori C; Tsujimoto M; Togawa Y; Kuwabara S
Neurology; 2022 Oct; 99(14):618-624. PubMed ID: 35918170
[TBL] [Abstract][Full Text] [Related]
31. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients.
Emmert S; Slor H; Busch DB; Batko S; Albert RB; Coleman D; Khan SG; Abu-Libdeh B; DiGiovanna JJ; Cunningham BB; Lee MM; Crollick J; Inui H; Ueda T; Hedayati M; Grossman L; Shahlavi T; Cleaver JE; Kraemer KH
J Invest Dermatol; 2002 Jun; 118(6):972-82. PubMed ID: 12060391
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
[TBL] [Abstract][Full Text] [Related]
33. Evidence that lack of deoxyribonucleic acid repair causes death of neurons in xeroderma pigmentosum.
Robbins JH; Polinsky RJ; Moshell AN
Ann Neurol; 1983 Jun; 13(6):682-4. PubMed ID: 6881931
[TBL] [Abstract][Full Text] [Related]
34. Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions.
Sethi M; Lehmann AR; Fawcett H; Stefanini M; Jaspers N; Mullard K; Turner S; Robson A; McGibbon D; Sarkany R; Fassihi H
Br J Dermatol; 2013 Dec; 169(6):1279-87. PubMed ID: 23889214
[TBL] [Abstract][Full Text] [Related]
35. [Xeroderma pigmentosum: children of the moon].
Herouy Y; Krutmann J; Norgauer J; Schöpf E
J Dtsch Dermatol Ges; 2003 Mar; 1(3):191-8. PubMed ID: 16285494
[TBL] [Abstract][Full Text] [Related]
36. DNA repair and ultraviolet mutagenesis in cells from a new patient with xeroderma pigmentosum group G and cockayne syndrome resemble xeroderma pigmentosum cells.
Moriwaki S; Stefanini M; Lehmann AR; Hoeijmakers JH; Robbins JH; Rapin I; Botta E; Tanganelli B; Vermeulen W; Broughton BC; Kraemer KH
J Invest Dermatol; 1996 Oct; 107(4):647-53. PubMed ID: 8823375
[TBL] [Abstract][Full Text] [Related]
37. Identification of a novel DDB2 mutation in a Chinese Han family with Xeroderma pigmentosum group E:a case report and literature review.
Yang R; Kong Q; Duan Y; Li W; Sang H
BMC Med Genet; 2020 Mar; 21(1):67. PubMed ID: 32228487
[TBL] [Abstract][Full Text] [Related]
38. Adult-Onset Neurodegeneration in Nucleotide Excision Repair Disorders (NERD
Cordts I; Önder D; Traschütz A; Kobeleva X; Karin I; Minnerop M; Koertvelyessy P; Biskup S; Forchhammer S; Binder J; Tzschach A; Meiss F; Schmidt A; Kreiß M; Cremer K; Mensah MA; Park J; Rautenberg M; Deininger N; Sturm M; Lingor P; Klopstock T; Weiler M; Marxreiter F; Synofzik M; Posch C; Sirokay J; Klockgether T; Haack TB; Deschauer M
Mov Disord; 2022 Aug; 37(8):1707-1718. PubMed ID: 35699229
[TBL] [Abstract][Full Text] [Related]
39. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa.
Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A
J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342
[TBL] [Abstract][Full Text] [Related]
40. [Neurological manifestations of xeroderma pigmentosum].
Boutaleb N; Ouhabi H; Bourazza A; Mosseddaq R
Rev Neurol (Paris); 2000 Sep; 156(8-9):790-3. PubMed ID: 10992126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
